ReviewFrontiers in cell and developmental biology2026
The developmental remodeling front: resorptive cell-vascular coupling at the chondro-osseous junction.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The chondro-osseous junction is commonly described as a site where cartilage is removed and bone is deposited, but this sequence does not explain how matrix topology is relayed into primary trabecular architecture. This review frames the junction as a developmental remodeling front in which cartilage-derived signals, endothelial advance, matrix-processing cell states, temporary scaffold retention, and osteoid deposition overlap in space and time. Mouse perturbation studies support vascular endothelial growth factor A (VEGF-A)-dependent entry, endothelial matrix metalloproteinase 9 (MMP-9)-mediated cartilage processing, endothelial Delta-like ligand 4 (Dll4)-Notch support of mesenchymal septoclasts, and state-specific interactions between endothelium and osteoclast-lineage cells. Recent evidence further shows that osteoclast-supporting receptor activator of nuclear factor-κB ligand (RANKL) sources change during development and that hypertrophic-chondrocyte Piezo1 modulates the local RANKL/osteoprotegerin (OPG) balance, arguing against a single, stage-invariant source model. The evidence nevertheless does not yet quantify the relative proteolytic contributions of endothelium and septoclasts or demonstrate that their timing directly specifies three-dimensional trabecular topology. Osteopetrosis, hypophosphatemic rickets, and collagen-X chondrodysplasia illustrate how similar cartilage-retention phenotypes can arise from distinct initiating compartments. A decisive test will require reciprocal, temporally restricted perturbations, activity-resolved imaging, anatomically matched three-dimensional reconstruction, and parallel adjacent-layer rescue. The remodeling-front framework therefore functions as a causal localization model and a set of falsifiable predictions rather than a single established pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.